Novartis reported $27.91B in Debt for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Debt Change
Amgen AMGN:US USD 38.94B 241M
AstraZeneca AZN:LN USD 29.23B 67M
Astrazeneca AZN:US USD 29.23B 67M
Biogen BIIB:US USD 6.28B 1.8M
Bristol Myers Squibb BMY:US USD 39.32B 222M
Canopy Growth Corp WEED:CN CAD 1.32B 158.19M
Catalent CTLT:US USD 4.85B 649M
Drreddys Laboratories RDY:US INR 17.66B 374M
Endo International Ordinary Shares ENDP:US USD 1.42M 8.09B
GlaxoSmithKline GSK:LN GBP 20.99B 1.13B
Glaxosmithkline GSK:US GBP 20.99B 1.13B
Horizon Pharma HZNP:US USD 2.56B 2.3M
Lannett LCI:US USD 623.86M 4.51M
Novartis NOVN:VX USD 27.91B 530M
Pacira Pharmaceuticals PCRX:US USD 689.47M 58.4M
Perrigo Ordinary Shares PRGO:US USD 4.11B 4.4M
Phibro Animal Health PAHC:US USD 476.23M 9.07M
Prestige Brands PBH:US USD 1.43B 14.93M
Roche Holding ROG:VX 25.35B 2.4B
Supernus Pharmaceuticals SUPN:US USD 401.97M 530K
Teva Pharmaceutical Industries TEVA:US USD 21.21B 54M
Valeant Pharmaceuticals VRX:CN USD 20.77B 449M
Zoetis ZTS:US USD 7.9B 1.34B